BBNX
Beta Bionics, Inc. Common Stock
NASDAQ: BBNX · HEALTHCARE · MEDICAL DEVICES
$9.90
-1.79% today
Updated 2026-04-29
Market cap
$441.16M
P/E ratio
—
P/S ratio
4.00x
EPS (TTM)
$-1.37
Dividend yield
—
52W range
$9 – $33
Volume
1.2M
WallStSmart proprietary scores
38
out of 100
Grade: D
Sell
Investment rating
6.3
Growth
B7.8
Quality
B+2.0
Profitability
F4.0
Valuation
C4/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$20.27
+104.75%
12-Month target
—
—
Intrinsic (DCF)
$10.61
Margin of safety
-33.08%
1 Strong Buy7 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 56.60% QoQ
+ Debt/equity 0.04x — low leverage
Risks
- Thin margins at -60.30%
- Negative free cash flow $-25.21M
- 33.08% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $179000.00 | $11.99M | $65.12M | $100.25M | $110.24M |
| Net income | $-64.75M | $-44.10M | $-54.76M | $-73.20M | $-21.89M |
| EPS | — | — | — | — | $-1.37 |
| Free cash flow | $-60.98M | $-32.85M | $-51.67M | $-56.22M | $-25.21M |
| Profit margin | -36,173.74% | -367.64% | -84.08% | -73.02% | -60.30% |
Peer comparison
Smart narrative
Beta Bionics, Inc. Common Stock trades at $9.90. Our Smart Value Score of 38/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $110.24M. with profit margins at -60.30%. Our DCF model estimates intrinsic value at $10.61.
Frequently asked questions
What is Beta Bionics, Inc. Common Stock's stock price?
Beta Bionics, Inc. Common Stock (BBNX) trades at $9.90.
Is Beta Bionics, Inc. Common Stock overvalued?
Smart Value Score 38/100 (Grade D, Sell). DCF value $10.61.
What is the price target of Beta Bionics, Inc. Common Stock (BBNX)?
The analyst target price is $20.27, representing +104.7% upside from the current price of $9.90.
What is the intrinsic value of Beta Bionics, Inc. Common Stock (BBNX)?
Based on our DCF model, intrinsic value is $10.61, a -33.1% margin of safety versus $9.90.
What is Beta Bionics, Inc. Common Stock's revenue?
TTM revenue is $110.24M.
Piotroski F-Score?
4/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.00x
ROE-22.70%
Beta—
50D MA$11.31
200D MA$19.17
Shares out0.04B
Float0.02B
Short ratio—
Avg volume1.2M
Performance
1 week-12.70%
1 month+8.01%
3 months-27.94%
YTD-65.05%
1 year—
3 years—
5 years—